Quality Analysis of Autologous Platelet-Rich Plasmapheresis

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2022 Oct 19

PMID 36258721

Authors

Nali Song

Zhongmei Yi

Qianying Ruan

Chenchen Li

Min Song

Bin Zhang

Affiliations

Soon will be listed here.

Abstract

To summarized the technology of autologous platelet-rich plasmapheresis and analyzed the product quality, in order to provide safe and effective product guarantee service for clinical treatment. Technical parameters were set according to patient age, weight, height, and preoperative routine blood indices. Autologous platelet-rich plasma (PRP) was collected, and the product quality and adverse reactions of patients were statistically analyzed. Autologous PRP had platelet (PLT), white blood cell (WBC), and red blood cell (RBC) counts of (1250.26 ± 435.88) × 10/L, (1.19 ± 1.95) × 10/L, and (0.05 ± 0.04) × 10/L, respectively. The PLT enrichment ratio in PRP was 5.66 ± 1.66. There was no significant difference in PLT, RBC, WBC, or hematocrit before and after apheresis ( > 0.05). The incidence of adverse reactions was 8%, and all were mild. When clinical patients use PRP in the treatment of diseases, autologous platelet-rich plasmapheresis technology was used to apheresis PRP, which has good product quality and few adverse reactions, and thus can be adopted more widely.

References

Devereaux J, Dargahi N, Fraser S, Nurgali K, Kiatos D, Apostolopoulos V . Leucocyte-Rich Platelet-Rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing. Int J Mol Sci. 2020; 21(18). PMC: 7556022. DOI: 10.3390/ijms21186519. View

Chou T, Chang H, Wang J . Autologous platelet concentrates in maxillofacial regenerative therapy. Kaohsiung J Med Sci. 2020; 36(5):305-310. DOI: 10.1002/kjm2.12192. View

Simon T . The collection of platelets by apheresis procedures. Transfus Med Rev. 1994; 8(2):132-45. DOI: 10.1016/s0887-7963(94)70105-x. View

Belk J, Kraeutler M, Houck D, Goodrich J, Dragoo J, McCarty E . Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2020; 49(1):249-260. DOI: 10.1177/0363546520909397. View

Kassir M, Kroumpouzos G, Puja P, Katsambas A, Galadari H, Lotti T . Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: A narrative review. J Cosmet Dermatol. 2020; 19(5):1057-1062. DOI: 10.1111/jocd.13376. View

Everts P, Onishi K, Jayaram P, Lana J, Mautner K . Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020; 21(20). PMC: 7589810. DOI: 10.3390/ijms21207794. View

Gentile P, Garcovich S . Systematic Review-The Potential Implications of Different Platelet-Rich Plasma (PRP) Concentrations in Regenerative Medicine for Tissue Repair. Int J Mol Sci. 2020; 21(16). PMC: 7460839. DOI: 10.3390/ijms21165702. View

McCarrel T, Minas T, Fortier L . Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012; 94(19):e143(1-8). DOI: 10.2106/JBJS.L.00019. View

Hermida-Nogueira L, Barrachina M, Moran L, Bravo S, Diz P, Garcia A . Deciphering the secretome of leukocyte-platelet rich fibrin: towards a better understanding of its wound healing properties. Sci Rep. 2020; 10(1):14571. PMC: 7471699. DOI: 10.1038/s41598-020-71419-7. View

10.

Gentile P, Calabrese C, De Angelis B, Dionisi L, Pizzicannella J, Kothari A . Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation. Int J Mol Sci. 2020; 21(2). PMC: 7014364. DOI: 10.3390/ijms21020431. View

11.

Aydin F, Pancar Yuksel E, Albayrak D . Platelet collection efficiencies of three different platelet-rich plasma preparation systems. J Cosmet Laser Ther. 2015; 17(3):165-8. DOI: 10.3109/14764172.2014.1003237. View

12.

Arora S, Doda V, Kotwal U, Dogra M . Quantification of platelets and platelet derived growth factors from platelet-rich-plasma (PRP) prepared at different centrifugal force (g) and time. Transfus Apher Sci. 2016; 54(1):103-10. DOI: 10.1016/j.transci.2016.01.028. View

13.

Kobayashi Y, Saita Y, Nishio H, Ikeda H, Takazawa Y, Nagao M . Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci. 2016; 21(5):683-9. DOI: 10.1016/j.jos.2016.07.009. View

14.

Mariani E, Canella V, Berlingeri A, Bielli A, Cattini L, Landini M . Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro. BMC Microbiol. 2015; 15:149. PMC: 4520275. DOI: 10.1186/s12866-015-0482-9. View

15.

Mazzocca A, McCarthy M, Chowaniec D, Dugdale E, Hansen D, Cote M . The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med. 2012; 40(8):1742-9. DOI: 10.1177/0363546512452713. View

16.

Liebig B, Kisiday J, Bahney C, Ehrhart N, Goodrich L . The platelet-rich plasma and mesenchymal stem cell milieu: A review of therapeutic effects on bone healing. J Orthop Res. 2020; 38(12):2539-2550. PMC: 8354210. DOI: 10.1002/jor.24786. View